GlassScriptPhysician profile
Barbara Pittaras
NPI 1063571743
$1,178.93
in general payments reported to CMS, 2019-2025
9 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $108 · 2023: $327 · 2024: $278 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $309.42 | 2019-2023 | Total30 |
| Bausch & Lomb Americas INC. | $173.56 | 2023-2025 | Miebo, Xiidra |
| Biotissue Holdings INC. | $140.28 | 2024 | |
| Glaukos Corporation | $137.76 | 2024 | Ce-Marked Kxla System |
| Tarsus Pharmaceuticals, INC. | $121.84 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $116.37 | 2023 | Cequa |
| Coopervision INC. | $113.87 | 2019-2020 | |
| Allergan, INC. | $46.43 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Pittaras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.